lobbying_activities: 1113250
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1113250 | 3d5ebf68-0236-4bf7-9a95-904ab5b55689 | Q2 | MCKENNA, LONG & ALDRIDGE | 76913 | REVANCE THERAPEUTICS, INC. | 2011 | second_quarter | PHA | Any issues impacting biopharmaceutical companies | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-07-14T22:14:35.867000-04:00 |